Search hospitals > Quebec > SHERBROOKE
Centre de Recherche du CHUS
Claim this profileSHERBROOKE, Quebec J1H 5N4
Conducts research for Type 2 Diabetes
Conducts research for Obesity
Conducts research for Diabetes
Conducts research for Prediabetes
Conducts research for Healthy Adults
39 reported clinical trials
6 medical researchers
Summary
Centre de Recherche du CHUS is a medical facility located in SHERBROOKE, Quebec. This center is recognized for care of Type 2 Diabetes, Obesity, Diabetes, Prediabetes, Healthy Adults and other specialties. Centre de Recherche du CHUS is involved with conducting 39 clinical trials across 56 conditions. There are 6 research doctors associated with this hospital, such as Éric Turcotte, MD, Mélanie Morin, PT, PhD, Andre Carpentier, and Denis Blondin.Top PIs
Éric Turcotte, MDCentre de recherche du CHUS1 year of reported clinical research
Studies Contagious Diseases
Studies Infectious Diseases
6 reported clinical trials
9 drugs studied
Mélanie Morin, PT, PhDCentre de Recherche du Centre Hospitalier Universitaire de Sherbrooke5 years of reported clinical research
Studies Painful Intercourse
Studies Gynecological Cancers
2 reported clinical trials
1 drug studied
Andre CarpentierCentre intégré universitaire de santé et de services sociaux de l'Estrie Centre Hospitalier Universitaire de Sherbrooke (CIUSSS de lEstrie-CHUS)5 years of reported clinical research
Studies Diabetes
Studies Type 1 Diabetes
2 reported clinical trials
5 drugs studied
Denis BlondinCentre de recherche du CHUS3 years of reported clinical research
Studies Type 2 Diabetes
Studies Prediabetes
2 reported clinical trials
3 drugs studied
Clinical Trials running at Centre de Recherche du CHUS
Type 2 Diabetes
Obesity
Diabetes
Chronic Kidney Disease
Urinary Incontinence
Bedwetting
Gynecologic Cancers
Prediabetes
Health Behaviors
Pregnancy Complications
Brown Fat Activation Treatments
for Type 2 Diabetes
Activation of brown adipose tissue (BAT) by cold exposure. BAT thermogenesis and BAT volume of metabolic activity will be assessed by Positron-Emitting-Tomography (PET/CT) and MRI/MRS imaging and new pharmacological methods to modulate BAT thermogenesis. All previous data on the functioning of Brown Adipose Tissue (BAT) were obtained by Positron-Emitting-Tomography (PET) imaging studies using fluorodeoxyglucose F18 ( \[18F\]- FDG). This approach underestimates the actual activity of the BAT. In this study, the investigator is going to use a new PET tracer (C11-palmitate) which is a fat molecule. This will allow to quantify more accurately the activity of brown fat.
Recruiting3 awards N/A2 criteria
Bariatric Surgery
for Type 2 Diabetes
The present protocol aims to understand and establish whether there is a causal link between adipose tissue metabolic remodeling and Type 2 Diabetes (T2D) remission after bariatric surgery. All participants will have a bariatric surgery, divided in 2 groups: with or without T2D.
Recruiting1 award N/A5 criteria
Tirzepatide
for Obesity and Chronic Kidney Disease
This trial is testing tirzepatide to see if it can help people with obesity, with or without type 2 diabetes, who have chronic kidney disease. The medication works by controlling blood sugar and reducing weight, which may improve kidney function. Tirzepatide is a new medication given regularly, effective in treating obesity in patients with and without diabetes.
Recruiting0 awards Phase 2
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Centre de Recherche du CHUS?
Centre de Recherche du CHUS is a medical facility located in SHERBROOKE, Quebec. This center is recognized for care of Type 2 Diabetes, Obesity, Diabetes, Prediabetes, Healthy Adults and other specialties. Centre de Recherche du CHUS is involved with conducting 39 clinical trials across 56 conditions. There are 6 research doctors associated with this hospital, such as Éric Turcotte, MD, Mélanie Morin, PT, PhD, Andre Carpentier, and Denis Blondin.